NCT01282814View on ClinicalTrials.gov

Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Sprinkle Study

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

February 28, 2003

Primary Completion Date

March 31, 2003

Study Completion Date

March 31, 2003

Conditions
Healthy
Interventions
DRUG

Venlafaxine Hydrochloride

150 mg Extended-Release Capsule

DRUG

Effexor® XR

150 mg Extended-Release Capsule

Trial Locations (1)

G1V 2K8

Anapharm Inc., Sainte-Foy

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT01282814 - Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Sprinkle Study | Biotech Hunter | Biotech Hunter